3-(4-Pentoxyphenyl)prop-2-enehydroxamic acid

ADVERTISEMENT

Identification

Molecular formula
C14H19NO3
CAS Number
Not available
IUPAC Name
3-(4-pentoxyphenyl)prop-2-enehydroxamic acid
Molecular Weight
235.30g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1450g/cm3
Interesting facts

Interesting Facts about 3-(4-pentoxyphenyl)prop-2-enehydroxamic acid

3-(4-pentoxyphenyl)prop-2-enehydroxamic acid is a fascinating compound that belongs to a class known for its diverse applications in the fields of chemistry and biochemistry. Here are some noteworthy aspects:

  • Hydroxamic Acid Derivative: This compound is a derivative of hydroxamic acid, which is widely recognized for its role in various biological activities, including as a class of inhibitors for metalloproteins.
  • Pharmaceutical Potential: Compounds like 3-(4-pentoxyphenyl)prop-2-enehydroxamic acid have attracted attention for their potential use in drug development, particularly in anti-cancer and antiviral therapies.
  • Structure and Function: The unique structure of this molecule allows it to interact specifically with certain enzymes, potentially altering their activity. This relationship highlights the importance of structure-activity relationships in medicinal chemistry.
  • Art of Synthesis: The synthesis of hydroxamic acids often involves creative methods, such as the reaction of amides with nitrous acid. This demonstrates a significant aspect of organic synthesis that emphasizes both creativity and precision.
  • Emerging Research: Recent studies have investigated the ability of hydroxamic acids to act as chelating agents for metal ions, which can have implications in environmental science and waste management.

In conclusion, 3-(4-pentoxyphenyl)prop-2-enehydroxamic acid is not only a compound of scientific interest but also a gateway to understanding broader concepts in chemical interactions and therapeutic applications. As noted by researchers, "The future of hydroxamic acid derivatives in drug discovery is promising, opening up new avenues for innovative treatments."

ADVERTISEMENT